Clinical trials
Diabetes Mellitus trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
133 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 4 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 12 |
| 2008 | 3 |
| 2009 | 12 |
| 2010 | 13 |
| 2011 | 8 |
| 2012 | 6 |
| 2013 | 9 |
| 2014 | 9 |
| 2015 | 8 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 5 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 105 |
| Terminated | 11 |
| Unknown status | 10 |
| Recruiting | 4 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 53 |
| Medical University of Graz | 11 |
| Medical University of Vienna | 11 |
| AstraZeneca | 8 |
| Allergan | 3 |
| Takeda | 3 |
| CeQur Corporation | 2 |
| Eli Lilly and Company | 2 |
| German Diabetes Center | 2 |
| Medical University Innsbruck | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 133 |
| Diabetes Mellitus, Type 2 | 52 |
| Diabetes Mellitus, Type 1 | 31 |
| Obesity | 9 |
| Coronary Artery Disease | 7 |
| Insulin Resistance | 7 |
| Cardiovascular Diseases | 6 |
| Glucose Metabolism Disorders | 5 |
| Atherosclerosis | 4 |
| Hyperlipidemias | 4 |
Trials
Showing 26 to 50 of 133. Each trial links to its page on Pharma Observatory.
33 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.